A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 163
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : HM
Long Form : hydatidiform mole
No. Year Title Co-occurring Abbreviation
2019 A Novel Mutation in NLRP7 Related to Recurrent Hydatidiform Mole and Reproductive Failure. CHM, PCR, PHM, RHM
2019 Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes. CC, CI, GTN
2019 Delivery of Euthyroid Baby following Hyperthyroidism in Twin Gestation with Coexisting Complete Hydatidiform Mole. GTD, GTH, hCG, TSH
2019 Expression of p57 immunomarker in the classification and differential diagnosis of partial and complete hydatidiform moles. CM, PM
2019 Gestational trophoblastic neoplasia: experience at Salah Azaiez Institute. GTD, GTN
2019 Heuristic neural network approach in histological sections detection of hydatidiform mole. MNN
2019 Identification of a hydatidiform mole in twin pregnancy following assisted reproduction. POC
2019 Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21WAF1/Cip1, p63 and Ki-67 expression in hydatidiform moles. CHM, HA, PHM
2019 Incidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study. CI, GTD, HIRA-NIS, OR
10  2019 Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia. ---
11  2019 Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues. CHM, FFPE, FISH, PHM
12  2019 miR-196b inhibits cell migration and invasion through targeting MAP3K1 in hydatidiform mole. CCK-8, miRNAs
13  2019 Overexpression of iASPP is required for autophagy in response to oxidative stress in choriocarcinoma. GTD
14  2019 p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types. Abs
15  2019 Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: a systematic review and meta-analysis. ---
16  2019 [Epidemioclinical and ultrasonographic profile of hydatidiform moles in Abidjan]. ---
17  2018 A bioinformatics transcriptome meta-analysis highlights the importance of trophoblast differentiation in the pathology of hydatidiform moles. ---
18  2018 Clinical and genetic-epignetic aspects of recurrent hydatidiform mole: A review of literature. CHM, GTD, KHDC3L, PHM
19  2018 Differential expression of leukemia inhibitory factor and insulin like growth factor-1 between normal pregnancies, partial hydatidiform moles and complete hydatidiform moles. IGF-1, LIF
20  2018 Hydatidiform mole: validity of the registration in the Danish National Patient Registry, the Danish Cancer Registry, and the Danish Pathology Registry 1999-2009. DCR, DPR, NPR, PPV
21  2018 Identification of microRNA signature in the progression of gestational trophoblastic disease. CHM, GTD, GTN, miRNA
22  2018 Identification of nonsynonymous TP53 mutations in hydatidiform moles. ---
23  2018 Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study. GTN, PHM
24  2018 What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients. hCG, pGTN, UHM
25  2017 Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience. ---
26  2017 F10, a novel hydatidiform mole-associated gene, inhibits the paclitaxel sensitivity of A549 lung cancer cells by downregulating BAX and caspase-3. Bax
27  2017 Low molecular weight hyaluronan induces migration of human choriocarcinoma JEG-3 cells mediated by RHAMM as well as by PI3K and MAPK pathways. CC, GTD, HA, PSTT
28  2017 miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells. CCA
29  2017 Pathogenic variant in NLRP7 (19q13.42) associated with recurrent gestational trophoblastic disease: Data from early embryo development observed during in vitro fertilization. IVF
30  2017 Qualitative and quantitative analysis of diffusion-weighted imaging of gestational trophoblastic disease: Can it predict progression of molar pregnancy to persistent form of disease? ADC, DWI, GTD, TSE
31  2017 Risk Factors for Hydatidiform Mole: Is Husband’s Job a Major Risk Factor? GTD, GTN
32  2017 Role of Surgery in the Management of Hydatidiform Mole in Elderly Patients: A Single-Center Clinical Experience. GTN, hCG
33  2016 A 10-Year Clinical Experience of Gestational Trophoblastic Disease at Rajavithi Hospital, 2001-2010. GTD, GTN, hCG
34  2016 A Reappraisal of the Incidence of Placental Hydatidiform Mole Using Selective Molecular Genotyping. CM, MG, PM
35  2016 Diginyc partial hydatidiform mole with increased fetal nuchal translucency and ovarian hyperstimulation syndrome. NT, PHM
36  2016 Evaluation of sialic acid levels in patients with hydatidiform mole: a preliminary study. SA
37  2016 Single nucleotide polymorphism-based microarray analysis for the diagnosis of hydatidiform moles. CNVs, SNP
38  2016 The hydatidiform mole. CHM, PHM
39  2016 Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study. GTD
40  2016 [⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective. CC, CT, ETT, GTD, PET, PSTT
41  2015 Epidemiology of Hydatidiform Moles in a Tertiary Hospital in Thailand over Two Decades: Impact of the National Health Policy. GTD, GTN, KCMH
42  2015 Live births in women with recurrent hydatidiform mole and two NLRP7 mutations. RHM
43  2015 Placental Molar Disease: What are the Benefits and Barriers to the Adoption of a Comprehensive Diagnostic Service? PMD
44  2015 Risk of recurrent molar pregnancies following complete and partial hydatidiform moles. CM, FRHM, GTN, PM
45  2014 Abnormal liver function test in hydatidiform moles: a retrospective study comparing the hyperthyroid state and the euthyroid state. AST, beta-hCG
46  2014 Complete hydatidiform mole and a coexistent fetus following ovulation induction in a patient with Sheehan's syndrome: a first case report and review of literature. CHM, SS
47  2014 Comprehensive genotype-phenotype correlations between NLRP7 mutations and the balance between embryonic tissue differentiation and trophoblastic proliferation. POC
48  2014 Current clinical features of complete and partial hydatidiform mole in Sweden. ---
49  2014 Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression. GTD
50  2014 Ectopic Complete Hydatidiform Mole Presenting as an Adnexal Tumor in a Postmenopausal Patient. ---
51  2014 Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: results after 12 years since International FIGO 2000 Consensus. GTD, GTN, PSTT
52  2014 Genetics and Epigenetics of Recurrent Hydatidiform Moles: Basic Science and Genetic Counselling. GTD, RHMs
53  2014 Gestational throphoblastic diseases in North East of Iran: 10 years (2001-2010) prospective epidemiological and clinicopathological study. GTD
54  2014 Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study. CIs, ORs
55  2014 Ovarian and adrenal androgens and their link to high human chorionic gonadotropin levels: a prospective controlled study. DHEAS, hCG
56  2014 [The expression of EMT associated protein CK-18 and vimentin in gestational trophoblastic disease ]. CK-18, EMT, GTD, GTN
57  2013 Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. CHM, PHM
58  2013 Gestational trophoblastic diseases in Turkey. ---
59  2013 NLRP7 and the Genetics of Hydatidiform Moles: Recent Advances and New Challenges. NLRPs
60  2013 Outcome of subsequent pregnancies in familial molar pregnancy. ---
61  2013 Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type. CHM, FTDC, GTN, PHM
62  2012 Hydatidiform mole in Turkey: results from six centers. ---
63  2012 Hydatidiform mole resulting from sexual violence. ---
64  2012 Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study. GTN, OIs
65  2012 Molar pregnancy in adolescents. GTN
66  2012 Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. CI, CM, ERPC, GTN, MD, MeSH, P-Chem, RCTs
67  2012 Temporal trends in the frequency of hydatidiform mole in lombardy, northern Italy, 1996-2008. ---
68  2011 Diandric triploid hydatidiform mole with loss of maternal chromosome 11. GTD, PHM
69  2011 Increase in the incidence of gestational trophoblastic disease in The Netherlands. GTD, PSTT
70  2011 Mosaics and moles. PTD
71  2011 NLRP7, a nucleotide oligomerization domain-like receptor protein, is required for normal cytokine secretion and co-localizes with Golgi and the microtubule-organizing center. ---
72  2011 No association between serum paraoxonase, arylesterase activities, and hydatidiform mole. PON1
73  2011 p57KIP2 immunohistochemical expression: a useful diagnostic tool in discrimination between complete hydatidiform mole and its mimics. CHM, PHM
74  2011 Prognostic significance of soluble fas and soluble fas ligand in serum of patients with complete hydatidiform moles. CHMs, PTD, sFas, sFasL
75  2011 Recurrent hydatidiform mole: A case report of six consecutive molar pregnancies complicated by choriocarcinoma, and review of the literature. ---
76  2011 Reporting and incidence trends of hydatidiform mole in Sweden 1973-2004. IPR, SCR
77  2011 The genetics of recurrent hydatidiform moles in China: correlations between NLRP7 mutations, molar genotypes and reproductive outcomes. ARTs
78  2010 Current issues in the histopathology of gestational trophoblastic tumors. CC, ETT, GTN, GTTs, hCG, PSTT
79  2010 Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications. GTN, hCG
80  2010 p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease. GTD, PAKs
81  2009 Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. CHM, eCHM, PHM
82  2009 Hydatidiform mole as seen in a university teaching hospital: a 10-year review. UMTH
83  2009 Recognising gestational trophoblastic disease. CHM, GTD, PHM, TVS
84  2009 Ultrasound imaging after evacuation as an adjunct to beta-hCG monitoring in posthydatidiform molar gestational trophoblastic neoplasia. GTN
85  2008 Activated Stat3 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and apoptotic indices. dUTP, ETT, GTD, GTN, PSTT, STAT, TdT
86  2008 Complete hydatidiform mole with coexisting dichorionic diamniotic twins following testicular sperm extraction and intracytoplasmic sperm injection. ICSI
87  2008 Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. ---
88  2008 Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia. GTN, PCR, PSCA
89  2008 Regional perspectives on gestational trophoblastic disease in Turkey. GTDs, MAC
90  2007 The genetics of hydatidiform moles: new lights on an ancient disease. ---
91  2007 [Clinical analysis of patients with lung metastasis of invasive mole before evacuation of hydatidiform mole]. IM
92  2006 Complete hydatidiform mole and normal live birth following intracytoplasmic sperm injection. ICSI
93  2006 Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta. aPM, CM, MMPs, p53wt, PM, TIMP
94  2006 Familial hydatidiform molar pregnancy: the germline imprinting defect hypothesis? ---
95  2006 Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. CHM
96  2006 Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. ---
97  2006 Recurrent partial hydatidiform mole: a report of a patient with three consecutive molar pregnancies. ---
98  2006 Trophoblastic reminiscences. GTD
99  2005 Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: combined cDNA suppression subtractive hybridization and microarray study. FTL, GTN, IGFBP-1, PCR, SSH
100  2005 Id helix-loop-helix proteins are differentially expressed in gestational trophoblastic disease. GTN